BYETTA Provided Greater Glycemic Durability and Overall Glycemic Control than Amaryl in ...
New Clinical Data Presented at 2012 ADA/The Lancet Symposium also Showed Patients Treated with BYETTA Experienced Reductions in Body Weight and Fewer Hypoglycemic Events
Original Article: BYETTA Provided Greater Glycemic Durability and Overall Glycemic Control than Amaryl in ...
NEXT ARTICLE